Federal contract award
HHSO10033002T
IGF::OT::IGF FOR OTHER FUNCTIONS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541711 |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | HHSO100201700011I |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $2.4M |
| Current contract value | $2.4M |
| Potential contract value / ceiling | $2.4M |
| Start date | Jul 29, 2017 |
| Current end date | Dec 31, 2021 |
| Potential end date | Apr 5, 2026 |
| Latest award activity | Apr 21, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 15 of 15 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 21, 2026 | P00014 | $45.7K | CHARACTERIZATION OF THE DISEASE COURSE IN RHESUS MACAQUES INFECTED WITH ZAIRE EBOLAVIRUS |
| Sep 12, 2024 | P00013 | $1.2K | CHARACTERIZATION OF THE DISEASE COURSE IN RHESUS MACAQUES INFECTED WITH ZAIRE EBOLAVIRUS |
| Oct 26, 2021 | P00012 | $0 | CHARACTERIZATION OF THE DISEASE COURSE IN RHESUS MACAQUES INFECTED WITH ZAIRE EBOLAVIRUS |
| Sep 17, 2021 | P00011 | $0 | CHARACTERIZATION OF THE DISEASE COURSE IN RHESUS MACAQUES INFECTED WITH ZAIRE EBOLAVIRUS |
| Aug 20, 2021 | P00010 | $0 | CHARACTERIZATION OF THE DISEASE COURSE IN RHESUS MACAQUES INFECTED WITH ZAIRE EBOLAVIRUS |
| May 27, 2021 | P00009 | $0 | CHARACTERIZATION OF THE DISEASE COURSE IN RHESUS MACAQUES INFECTED WITH ZAIRE EBOLAVIRUS |
| Dec 10, 2020 | P00008 | $0 | CHARACTERIZATION OF THE DISEASE COURSE IN RHESUS MACAQUES INFECTED WITH ZAIRE EBOLAVIRUS |
| Jul 15, 2020 | P00007 | $0 | CHARACTERIZATION OF THE DISEASE COURSE IN RHESUS MACAQUES INFECTED WITH ZAIRE EBOLAVIRUS |
| Dec 10, 2019 | P00006 | $0 | CHARACTERIZATION OF THE DISEASE COURSE IN RHESUS MACAQUES INFECTED WITH ZAIRE EBOLAVIRUS |
| Jun 21, 2019 | P00005 | $0 | IGF::OT::IGF FOR OTHER FUNCTIONS |
| Jan 28, 2019 | 4 | $0 | IGF::OT::IGF FOR OTHER FUNCTIONS |
| Dec 11, 2018 | 3 | $0 | IGF::OT::IGF FOR OTHER FUNCTIONS |
| Oct 29, 2018 | 2 | $0 | IGF::OT::IGF FOR OTHER FUNCTIONS |
| Jul 12, 2018 | 1 | $0 | IGF::OT::IGF FOR OTHER FUNCTIONS |
| Jul 29, 2017 | 0 | $2.4M | IGF::OT::IGF FOR OTHER FUNCTIONS |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.